New Monoclonal Antibody and Vaccine Can Protect Kids from RSV

Nirsevimab (brand name: Beyfortus™) and Abrysvo™, a vaccine given to pregnant women are new preventive options for respiratory syncytial virus (RSV) that could help keep vulnerable infants and toddlers out of the hospital this year. Yale Medicine experts tell you what you need to know.